Core Insights - Bio-Techne Corporation announced advancements in its spatial biology portfolio, specifically for RNAscope™ ISH technology and Lunaphore COMET™, which enhance the detection of RNA and protein biomarkers on the same tissue section [1][7]. Product Advancements - RNAscope™ technology allows pathologists to detect clinically relevant biomarkers within routine anatomic pathology workflows, while COMET™ provides fully automated, high-throughput hyperplex analysis of RNA and protein biomarkers, facilitating spatial multiomic workflows [2][7]. - The integration of these technologies into diagnostic workflows is being explored, particularly for assessing B-cell clonality and spatial profiling of lymphoid malignancies [3][7]. Event Participation - Bio-Techne will showcase its innovations at the National Society of Histotechnology (NSH) Convention from September 26–30 in Long Beach, CA, with presentations highlighting the advantages of RNAscope™ and its applications in clinical diagnostics [4][8]. Research Highlights - Studies presented include the use of RNAscope™ for assessing B-cell clonality and the application of COMET™ for spatial profiling of lymphoid malignancies, demonstrating the potential clinical utility of these technologies [3][8]. Company Overview - Bio-Techne Corporation is a global life sciences company that generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people worldwide, providing innovative tools and reagents for research and clinical diagnostics [9].
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications